TLR4 and necrotizing enterocolitis: Additionally, a study by Liu et al. (72) revealed that the expression levels of both TLR4 and necroptosis-related proteins are upregulated in NEC patients and animal models; moreover, inhibiting necroptosis can significantly alleviate intestinal inflammatory injury, indicating that anti-necroptosis therapy is a potential direction for relieving NEC symptoms.